freedomstocks

Gilead Sciences (GILD) Initiates Phase 3 Study for novel Coronavirus vaccine

Gilead Sciences (NASDAQ: GILD) today announced the initiation of two phase 3 clinical studies for the novel Coronavirus. The study aims to evaluate the efficacy of remdesivir in adults diagnosed with COVID-19. Find winning trades …

Gilead Sciences (GILD) Initiates Phase 3 Study for novel Coronavirus vaccine Read More »

BioXcel Therapeutics (NASDAQ: BTAI) announces initiation of phase 2 study

BioXcel Therapeutics Inc. (NASDAQ: BTAI) announced the initiation of a Phase 2 study by researchers at Yale University. The research is designed to measure biomarkers associated with agitation in patients with schizophrenia. The company will …

BioXcel Therapeutics (NASDAQ: BTAI) announces initiation of phase 2 study Read More »

Scroll to Top